solifenacin succinate

FDA Drug Profile — solifenacin succinate, VESIcare, Solifenacin succinate, Solifenacin Succinate, VESIcare LS

solifenacin succinate is listed in the FDA National Drug Code directory with 20 NDC codes, marketed under brand names including solifenacin succinate, VESIcare, Solifenacin succinate. Available dosage forms: tablet, coated, tablet, film coated, powder, tablet, film coated, extended release, suspension.

Drug Details

Generic Name
solifenacin succinate
Brand Names
solifenacin succinate, VESIcare, Solifenacin succinate, Solifenacin Succinate, VESIcare LS
Application Number
ANDA204374
Sponsor
Macleods Pharmaceuticals Limited
NDC Codes
20
Dosage Forms
TABLET, COATED, TABLET, FILM COATED, POWDER, TABLET, FILM COATED, EXTENDED RELEASE, SUSPENSION
Routes
ORAL
Active Ingredients
SOLIFENACIN SUCCINATE

Indications and Usage

1 INDICATIONS AND USAGE Solifenacin Succinate Tablets are indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Solifenacin Succinate Tablets are a muscarinic antagonist indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. ( 1 )